Your browser doesn't support javascript.
loading
Long term follow-up of EGFR mutated NSCLC cases.
Rennert, Gad; Gottfried, Maya; Rennert, Hedy S; Lejbkowicz, Flavio; Frank, Meira; Cohen, Ilana; Kelt, Shiri; Agbarya, Abed; Dudnik, Elizabeta; Dudnik, Julia; Katznelson, Rivka; Mishali, Moshe; Maimon Rabinovich, Natalie; Nechushtan, Hovav; Onn, Amir; Keren Rosenberg, Shoshana; Wollner, Mariana; Zer, Alona; Bar, Jair; Gronich, Naomi.
Afiliación
  • Rennert G; Clalit Health Services National Cancer Control Center and Personalized Medicine Program, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Office of Chief Physician, Clalit He
  • Gottfried M; Lung Cancer Unit, Meir Medical Center, 4428164 Kfar Saba, Israel.
  • Rennert HS; Clalit Health Services National Cancer Control Center and Personalized Medicine Program, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Lejbkowicz F; Clalit Health Services National Cancer Control Center and Personalized Medicine Program, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Frank M; Clalit Health Services National Cancer Control Center and Personalized Medicine Program, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Cohen I; Clalit Health Services National Cancer Control Center and Personalized Medicine Program, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Kelt S; Clalit Health Services National Cancer Control Center and Personalized Medicine Program, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Agbarya A; Oncology Unit, Bene Zion Medical Center, Haifa, Israel.
  • Dudnik E; Thoracic Cancer Unit, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
  • Dudnik J; Department of Oncology, Soroka University Medical Center (SUMC) and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
  • Katznelson R; Institute of Oncology, Kaplan Medical Center, Rehovot, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Mishali M; Lung Cancer Unit, Meir Medical Center, 4428164 Kfar Saba, Israel.
  • Maimon Rabinovich N; Lung Cancer Unit, Meir Medical Center, 4428164 Kfar Saba, Israel.
  • Nechushtan H; Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.
  • Onn A; Institute of Pulmonology, Sheba Medical Center, Tel Hashomer, Israel.
  • Keren Rosenberg S; Oncology Institute, Lin Medical Center and Carmel Medical Center, Haifa, Israel.
  • Wollner M; Department of Oncology, Rambam Health Care Campus, Haifa, Israel.
  • Zer A; Thoracic Cancer Unit, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
  • Bar J; Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.
  • Gronich N; Clalit Health Services National Cancer Control Center and Personalized Medicine Program, Israel; Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Transl Oncol ; 14(1): 100934, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33186889

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Transl Oncol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Transl Oncol Año: 2021 Tipo del documento: Article